# Top 50 Biotech VC (Venture Capital) Funds in October 2023

| Investor | Relevant Deals | Geography | Stage | Focus |
| --- | --- | --- | --- | --- |
| ARCH Venture Partners | 112 | United States, China, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| OrbiMed | 95 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical |
| Sofinnova Partners | 84 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical |
| Alexandria Venture Investments | 82 | United States, France, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Versant Ventures | 74 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical |
| Novo Holdings | 72 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical |
| New Enterprise Associates | 71 | United States, India, China | Series B, Series A, Series C | Software, Health Care, Biotechnology |
| F-Prime Capital | 66 | United States, United Kingdom, China | Series A, Series B, Series C | Health Care, Biotechnology, Medical |
| Atlas Venture | 66 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| MPM Capital | 64 | United States, Canada, Germany | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical |
| 5AM Ventures | 64 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Innova Memphis | 63 | United States, Argentina, United Kingdom | Seed, Pre-Seed, Convertible Note | Health Care, Medical, Medical Device |
| Khosla Ventures | 60 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Health Care, Artificial Intelligence |
| Polaris Partners | 60 | United States, Singapore, Ireland | Series B, Series A, Series C | Biotechnology, Health Care, Medical |
| Novartis Venture Fund | 57 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| RA Capital Management | 56 | United States, United Kingdom, China | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| Third Rock Ventures | 55 | United States | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| M Ventures | 54 | United States, Switzerland, United Kingdom | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics |
| Canaan Partners | 53 | United States, Israel, India | Series A, Series B, Series C | Software, Biotechnology, Health Care |
| UK Innovation & Science Seed Fund | 51 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Medical |
| Bpifrance | 51 | France, United States, Switzerland | Seed, Series A | Software, Health Care, Information Technology |
| Qiming Venture Partners | 51 | China, United States, Hong Kong | Series B, Series A, Series C | Health Care, Medical, Biotechnology |
| BioAdvance | 50 | United States, Canada | Seed, Series A | Biotechnology, Health Care, Medical |
| High-Tech Grunderfonds | 49 | Germany, Switzerland, United States | Seed, Series A | Software, Information Technology, Biotechnology |
| Takeda Ventures | 48 | United States, United Kingdom, Israel | Series A, Series B | Biotechnology, Health Care, Therapeutics |
| Boehringer Ingelheim Venture Fund | 45 | United States, Germany, Belgium | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics |
| Fifty Years | 45 | United States, Germany, Canada | Seed, Series A, Series B | Biotechnology, Health Care, Medical |
| SR One | 44 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Sequoia Capital China | 44 | China, United States, Australia | Series A, Series B, Series C | Health Care, Biotechnology, Artificial Intelligence |
| Pfizer Venture Investments | 43 | United States, United Kingdom, Switzerland | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| DCVC | 43 | United States, Canada, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Health Care |
| Lilly Asia Ventures | 42 | China, United States, Hong Kong | Series A, Series B, Series C | Biotechnology, Health Care, Medical |
| Parkwalk Advisors | 42 | United Kingdom, United States, Philippines | Seed, Series A, Series B | Biotechnology, Health Care, Software |
| Casdin Capital | 41 | United States, France, China | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| Seventure Partners | 41 | France, United States, Germany | Series A, Series B | Biotechnology, Health Care, Software |
| EQT life science | 41 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Lux Capital | 40 | United States, Canada, United Kingdom | Series A, Seed, Series B | Software, Health Care, Biotechnology |
| Sofinnova Investments | 40 | United States, France, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical |
| Andreessen Horowitz | 40 | United States, United Kingdom, Canada | Series A, Series B, Seed | Software, Information Technology, Internet |
| Frazier Healthcare Partners | 40 | United States, Canada, Ireland | Series B, Series A, Post-IPO Equity | Biotechnology, Health Care, Therapeutics |
| Connecticut Innovations | 40 | United States, Israel, Canada | Series A, Seed | Health Care, Biotechnology, Software |
| Google Ventures | 39 | United States, United Kingdom, Canada | Series B, Series A, Seed | Software, Health Care, Biotechnology |
| Hatteras Venture Partners | 39 | United States, Canada | Series A, Series B | Biotechnology, Health Care, Medical |
| Northpond Ventures | 38 | United States, United Kingdom, Australia | Series A, Series B, Series C | Biotechnology, Health Care, Life Science |
| Amgen Ventures | 37 | United States, United Kingdom, Canada | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| The Column Group | 37 | United States | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Scottish Investment Bank | 36 | United Kingdom, United States, France | Seed, Series A | Software, Biotechnology, Information Technology |
| Life Science Angels | 36 | United States, Israel, The Netherlands | Seed, Series A | Biotechnology, Health Care, Medical |
| Boston Harbor Angels | 36 | United States, Canada, India | Angel, Seed, Series A | Biotechnology, Health Care, Medical Device |
| HealthCap | 36 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical |

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co